homeindia News

ICMR study has shown rise in antibodies post Covaxin booster dose: MoS Health tells Rajya Sabha

ICMR study has shown rise in antibodies post Covaxin booster dose: MoS Health tells Rajya Sabha

ICMR study has shown rise in antibodies post Covaxin booster dose: MoS Health tells Rajya Sabha
Profile image

By PTI Mar 29, 2022 4:07:39 PM IST (Updated)

International data available on booster doses of AstraZeneca and Covishield suggests a three- to four-fold increase in antibody levels after their administration, Minister of State for Health Bharati Pravin Pawar told the Rajya Sabha on Tuesday.

An ICMR study to examine the effect of Covaxin's booster dose has shown an increase in the levels of antibodies against SARS-CoV-2, Minister of State for Health Bharati Pravin Pawar told the Rajya Sabha on Tuesday. International data available on booster doses of AstraZeneca and Covishield suggests a three- to four-fold increase in antibody levels after their administration, Pawar said in a written reply.

Recommended Articles

View All

"A study has been conducted by Indian Council of Medical Research (ICMR) to examine the effect of booster dose of Covaxin which shows increase in the levels of neutralising antibodies against SARS-CoV-2 after the booster dose," Pawar stated.
Also Read
As per the recommendation of the National Technical Advisory Group on Immunization (NTAGI), precaution dose is administered to healthcare workers, frontline workers, and people aged 60 years and above since January 10,2022, she said.
As on March 24, 2022, 2.21 crore precaution doses against COVID-19 have been administered.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers
    CurrencyCommodities
    CompanyPriceChng%Chng